Belgian biotech giant UCB (OTC: UCBJY) agreed to terms to acquire Ra Pharmaceuticals (NASDAQ: RARX) in an all-cash deal worth $2.1 billion USD. RARX shareholders will be paid $48 per share upon closing. Both company’s boards unanimously approved the deal, but shareholders and regulators need to approve the deal before it can be finalized. The acquisition […]
The post UCB to Acquire Ra Pharma; Shares Double on News appeared first on The Stock Dork.
source https://www.thestockdork.com/ucb-buys-rarx/
No comments:
Post a Comment